N,N'-diacetylchitobiose



Compound IDCDAMM00426
Common nameN,N'-diacetylchitobiose
IUPAC nameN-[5-[3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,4-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide
Molecular formulaC16H28N2O11

Experimental data

Retention time7.39
Adduct[M+H]+
Actual mz425.171
Theoretical mz425.176
Error12.88
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score7.3609

Identifiers and class information

Inchi keyCDOJPCSDOXYJJF-CBTAGEKQSA-N
SmilesO=C(NC1C(O)OC(CO)C(OC2OC(CO)C(O)C(O)C2NC(=O)C)C1O)C
SuperclassOrganic oxygen compounds
ClassOrganooxygen compounds

Pharmacokinetic properties

Number of descriptor values(#stars)6
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)2
Number of rotatable bonds (#rotor)12
Number of reactive functional groups (#rtvFG)2
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)424.404
Computed dipole moment(dipole)9.721
Total solvent accessible surface area (SASA)619.985
Hydrophobic component of SASA (FOSA)343.48
Hydrophilic component of SASA (FISA)276.505
Pie component of the SASA (PISA)0
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1166.68
Number of hydrogen bond donors (donorHB)8
Number of hydrogen bond acceptors (accptHB)20.3
Free energy of solvation of dipole (dip^2/V)0.0809893
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0926103
Globularity descriptor (glob)0.864473
Predicted polarizability in cubic angstroms (QPpolrz)32.831
Predicted hexadecane/gas partition coefficient (QPlogPC16)12.858
Predicted octanol/gas partition coefficient (QPlogPoct)34.594
Predicted water/gas partition coefficient (QPlogPw)35.227
Predicted octanol/water partition coefficient (QPlogPo/w)-4.435
Predicted aqueous solubility (QPlogS)-0.054
Conformation-independent predicted aqueous solubility (CIQPlogS)0.869
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-0.976
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)11.054
Predicted brain/blood partition coefficient (QPlogBB)-2.626
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)8.642
Predicted skin permeability, log Kp (QPlogKp)-5.463
PM3 calculated ionization potential (IP(ev))9.692
PM3 calculated electron affinity (EA(eV))-0.925
Number of likely metabolic reactions (#metab)5
Prediction of binding to human serum albumin (QPlogKhsa)-2.039
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)0
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)41.492
Van der Waals surface area (PSA)216.252
Number of nitrogen and oxygen atoms (#NandO)13
Number of violations of Lipinski’s rule of five (RuleOfFive)2
Number of violations of Jorgensen’s rule of three (RuleOfThree)1

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
O43570CA12Carbonic anhydrase XIIT16987SEA
Q16790CA9Carbonic anhydrase IXT64567SEA
P16278GLB1Beta-galactosidase (by homology)T73134SEA
Q9ULX7CA14Carbonic anhydrase XIVT31992SEA
Q9BZP6CHIAAcidic mammalian chitinase (by homology)T51597SEA
P15692VEGFAVascular endothelial growth factor AT20761SEA
P05230FGF1Acidic fibroblast growth factorT18639SEA
P09038FGF2Basic fibroblast growth factorT31621SEA
P52789HK2Hexokinase type IIT96685SEA
P01112HRASTransforming protein p21/H-Ras-1T71081SEA
P17931LGALS3Galectin-3T72038SwissTargetPrediction and SEA
P04746AMY2APancreatic alpha-amylaseT86918SEA
P14679TYRTyrosinaseT97035SEA
P20916MAGMyelin-associated glycoprotein (by homology)T95286SEA
P09382LGALS1Galectin-1T09544SEA
Q99417MYCBPMYCBP messenger RNAT37298SEA
Q07108CD69Early activation antigen CD69T48780SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T16987DI0046Bacterial infection[ICD-11: 1A00-1C4Z]O43570CA12
T16987DI0372Seborrhoeic dermatitis[ICD-11: EA81]O43570CA12
T64567DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]Q16790CA9
T73134DI0242Lysosomal disease[ICD-11: 5C56]P16278GLB1
T31992DI0046Bacterial infection[ICD-11: 1A00-1C4Z]Q9ULX7CA14
T31992DI0204Inborn metabolism deficiency[ICD-11: 5C50-5C59]Q9ULX7CA14
T20761DI0095Colorectal cancer[ICD-11: 2B91]P15692VEGFA
T20761DI0365Retinopathy[ICD-11: 9B71]P15692VEGFA
T20761DI0430Vascular system developmental anomaly[ICD-11: LA90]P15692VEGFA
T18639DI0081Chronic arterial occlusive disease[ICD-11: BD4Z]P05230FGF1
T18639DI0102Coronary atherosclerosis[ICD-11: BA52]P05230FGF1
T31621DI0005Acne vulgaris[ICD-11: ED80]P09038FGF2
T96685DI0133Epidermal dysplasias[ICD-11: EK90]P52789HK2
T72038DI0190Hypertension[ICD-11: BA00-BA04]P17931LGALS3
T72038DI0199Idiopathic interstitial pneumonitis[ICD-11: CB03]P17931LGALS3
T72038DI0252Melanoma[ICD-11: 2C30]P17931LGALS3
T72038DI0302Non-alcoholic fatty liver disease[ICD-11: DB92]P17931LGALS3
T72038DI0351Psoriasis[ICD-11: EA90]P17931LGALS3
T86918DI0110Cystic fibrosis[ICD-11: CA25]P04746AMY2A
T86918DI0328Pancreatic malfunction[ICD-11: DC30-DC3Z]P04746AMY2A
T97035DI0007Acquired hypermelanosis[ICD-11: ED60]P14679TYR
T97035DI0008Acquired hypomelanotic disorder[ICD-11: ED63]P14679TYR
T95286DI0219Ischaemic/haemorrhagic stroke[ICD-11: 8B20]P20916MAG
T37298DI0235Liver cancer[ICD-11: 2C12]Q99417MYCBP

Copyright © 2025